Insights

Innovative Eye Care Focus IACTA Pharmaceuticals specializes in developing innovative ophthalmic therapies aimed at addressing unmet medical needs, indicating an opportunity to supply advanced drug delivery technologies or specialized manufacturing services aligned with cutting-edge eye care solutions.

Growth Potential With current revenues between one and ten million dollars and recent strategic hires, the company is positioned for growth, offering potential sales of therapeutic ingredients, research collaborations, or manufacturing partnerships to support its expansion.

Partnership and Collaboration Established partnerships with organizations like Ora, Inc. showcase a collaborative approach that could open doors for joint development projects, shared technology platforms, or clinical research support opportunities.

Leadership Expansion The addition of experienced advisors and executives in scientific, medical, and financial roles suggests a company investing in leadership strength, which may turn into opportunities for professional service vendors, medical device suppliers, or strategic consulting.

Technology and Digital Engagement Utilizing a modern tech stack and maintaining a professional online presence, IACTA is engaged with digital tools, creating potential avenues for digital marketing, cloud solutions, or software services to enhance their R&D and commercial activities.

IACTA Pharmaceuticals Tech Stack

IACTA Pharmaceuticals uses 8 technology products and services including Font Awesome, Modernizr, imagesLoaded, and more. Explore IACTA Pharmaceuticals's tech stack below.

  • Font Awesome
    Font Scripts
  • Modernizr
    Javascript Libraries
  • imagesLoaded
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Google Tag Manager
    Tag Management
  • Adobe Fonts
    Web Fonts
  • IONOS
    Web Hosting
  • Apache
    Web Servers

Media & News

IACTA Pharmaceuticals's Email Address Formats

IACTA Pharmaceuticals uses at least 1 format(s):
IACTA Pharmaceuticals Email FormatsExamplePercentage
FL@iactapharma.comJD@iactapharma.com
89%
LF@iactapharma.comDJ@iactapharma.com
11%

Frequently Asked Questions

Where is IACTA Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
IACTA Pharmaceuticals's main headquarters is located at 19900 Macarthur Boulevard Suite 550 Irvine, California 92612 United States. The company has employees across 1 continents, including North America.

What is IACTA Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
IACTA Pharmaceuticals's official website is iactapharma.com and has social profiles on LinkedInCrunchbase.

What is IACTA Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
IACTA Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does IACTA Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of June 2026, IACTA Pharmaceuticals has approximately 9 employees across 1 continents, including North America. Key team members include Ceo And Founder: D. B.Chief Financial Officer And Head Of Investor Relations: Y. B.Chief Scientific Officer: F. O. O.. Explore IACTA Pharmaceuticals's employee directory with LeadIQ.

What industry does IACTA Pharmaceuticals belong to?

Minus sign iconPlus sign icon
IACTA Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does IACTA Pharmaceuticals use?

Minus sign iconPlus sign icon
IACTA Pharmaceuticals's tech stack includes Font AwesomeModernizrimagesLoadedjQuery MigrateGoogle Tag ManagerAdobe FontsIONOSApache.

What is IACTA Pharmaceuticals's email format?

Minus sign iconPlus sign icon
IACTA Pharmaceuticals's email format typically follows the pattern of FL@iactapharma.com. Find more IACTA Pharmaceuticals email formats with LeadIQ.

How much funding has IACTA Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of June 2026, IACTA Pharmaceuticals has raised $1M in funding. The last funding round occurred on Oct 28, 2021 for $1M.

IACTA Pharmaceuticals

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

IACTA Pharmaceuticals is a small biotechnology firm focused on ophthalmic therapeutics within the pharmaceutical manufacturing sector. The company aims to improve patient care by bringing innovative eye care technology into the healthcare system, while seeking to increase the efficacy and safety of existing eye medications and to develop new ophthalmic drugs that address unmet medical needs. It emphasizes leveraging external partnerships to identify and launch new technologies as treatments with global reach.
In Irvine, California, the company positions itself at the intersection of ophthalmic drug development and collaborative science, pursuing partnerships and licensing deals to advance its programs. Its activities are directed toward healthcare providers and patients who rely on eye care therapies, with the goal of better outcomes and safer treatments. A notable development in 2022 was the expansion of its Scientific Advisory Board with appointments of two new experts, reflecting an emphasis on guiding its research direction and clinical strategy.

Section iconCompany Overview

Headquarters
19900 Macarthur Boulevard Suite 550 Irvine, California 92612 United States
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $1M

    IACTA Pharmaceuticals has raised a total of $1M of funding over 1 rounds. Their latest funding round was raised on Oct 28, 2021 in the amount of $1M.

  • $1M$10M

    IACTA Pharmaceuticals's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M

    IACTA Pharmaceuticals has raised a total of $1M of funding over 1 rounds. Their latest funding round was raised on Oct 28, 2021 in the amount of $1M.

  • $1M$10M

    IACTA Pharmaceuticals's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.